CSI Market
Sign In | Register

Adaptimmune Therapeutics Plc (ADAP) Annual Balance Sheets

Annual · GAAP · USD millions
Access ADAP quarterly Balance Sheets →
The table below presents a historical view of Adaptimmune Therapeutics Plc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent91.14
Available-for-sale Securities, Debt Securities, Current MA60.47
Cash & Short-term Investments151.00
Accounts receivable1.45
Notes Receivable, Current1.60
Inventories7.32
Other Current Assets0.00
Prepaid Expense And Other Assets Current27.79
Total Current Assets188.17
Equipment/Property/Plant Net51.89
Intangible Assets5.57
Long-term investments2.07
Tax Assets, Noncurrent313.10
Other Assets, Noncurrent21.00
Total Assets245.96
Liabilities
Accounts Payable, Current AC8.69
Accrued Liabilities, Current AC32.92
Other Liabilities, Current22.92
Total Current Liabilities64.53
Long-term debt50.24
Total Long-term Debt50.24
Restructuring Reserve LI5.91
Deferred Revenue, Noncurrent DE95.82
Accrued Income Taxes, Noncurrent3.61
Discontinued Operation, Noncurrent5.91
Other liabilities, Noncurrent17.62
Operating Lease Liability Current4.71
Contract With Customer Liability Current12.30
Operating Lease Liability Noncurrent19.26
Total Liabilities234.11
Stockholders' Equity
Common Stock Value2.09
Additional Paid In Capital Common Stock1,105.65
Retained Earnings / Accumulated Deficit-1,093.99
Accumulated Other Comprehensive Income-1.90
Other Equity-1.90
Common Stockholder's Equity11.85
Total Stockholder's Equity11.85
Liabilities & Stockholder's Equity245.96
4 historic quarters locked

Sign in to unlock the full Adaptimmune Therapeutics Plc balance sheet history.

Sign In Create Free Account

About Adaptimmune Therapeutics Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-25-003544

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License